AeroLeads people directory · profile

Andy Chu Email & Phone Number

BioPharma R&D Business and Technology Executive at Sionna Therapeutics
Location: Cambridge, Massachusetts, United States 9 work roles 2 schools
1 work email found @biogen.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email a****@biogen.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
BioPharma R&D Business and Technology Executive
Location
Cambridge, Massachusetts, United States

Who is Andy Chu? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Andy Chu is listed as BioPharma R&D Business and Technology Executive at Sionna Therapeutics, based in Cambridge, Massachusetts, United States. AeroLeads shows a work email signal at biogen.com and a matched LinkedIn profile for Andy Chu.

Andy Chu previously worked as Vice President Information Technology at Sionna Therapeutics and Executive Director, Head of I&T at H3 Biomedicine. Andy Chu holds Bachelor'S Degree, G.S., Business Information Systems from Southern New Hampshire University.

Company email context

Email format at Sionna Therapeutics

This section adds company-level context without repeating Andy Chu's masked contact details.

{first}.{last}@biogen.com
86% confidence

AeroLeads found 1 current-domain work email signal for Andy Chu. Compare company email patterns before reaching out.

Profile bio

About Andy Chu

Dynamic executive, who thrives in fast paced environments. Ensures strategies remains in focus while ever delivering operational whether under significant change or during transformational periods of organizational development.• Innovative thought leader with 25+ years of experience from developing Biopharma start-ups to implementing global large scale strategic imperatives and realizing real world results at leading Pharma/Biotech/Medical Device companies• Repeatedly demonstrated versatility and holistic capabilities across Life Science Organizations – driving significant change, delivering quality improvements, providing high levels of customer satisfaction, and enabling key partnerships. Areas of Expertise*Strategic Planning and Leadership *Pharm/ Med Device R&D Business and Technology *Cross-Functional Team Leadership *Organizational Design and Development *Complex Problem Solving *Negotiation, Persuasion and Communication *Project Planning and Execution *Global Delivery Operations *Vendor and Services Management *Client and Customer Management *ITIL *ITSM *Lean Sigma *Risk Management and Decision Making *Budget and Financial Management *Process Improvements and Transformations *IT Application Operations *Enterprise Architecture *IT Roadmaps *Clinical Regulatory Compliance

Listed skills include Vendor Management, Outsourcing, Pharmaceutical Industry, Clinical Data Management, and 46 others.

Current workplace

Andy Chu's current company

Company context helps verify the profile and gives searchers a useful next step.

Sionna Therapeutics
Sionna Therapeutics
BioPharma R&D Business and Technology Executive
AeroLeads page
9 roles

Andy Chu work experience

A career timeline built from the work history available for this profile.

Vice President Information Technology

Current

Boston, MA, US

The inaugural Head of IT, brought in to development, and implement the strategic vision for all information systems and technology. The technology thought Leader, collaborating across Sionna leadership, and shepherding Sionna's IT and IT Security in the transition from early stage post-stealth as a pre-clinical biotech, and advancing as a clinical stage.

Sep 2022 - Present

Executive Director, Head Of I&T

H3 Biomedicine
  • As the overall Head of I&T (Informatics and Technology), reporting into the Deputy President (COO) of H3, bringing together a unified portfolio and capability driven approach to all aspects of information technology.
  • Recognized by parent company Eisai as top strategic leader, and selected into the Business Transformational Leadership Program (BTLP), which featured SECI/Design Thinking brought to life with real world fast.
  • Unified segmented Informatics & Enterprise IT groups into a cohesive I&T organization responsible for all H3 technology needs
  • Redesigned and transformed the structure and model of the I&T team, providing a focused support and delivery model against the capabilities model and roadmap
  • Introduced a new data paradigm and an unified architecture across the enterprise, anchored against a research-centric capabilities model, with a continuously evolving 3-year roadmap.
  • Influenced and led formally stagnant one-off approaches on bespoke aged applications and infrastructure into an implementation program that is cornerstone to the H3 Lab of the future
Aug 2020 - Sep 2022

Director, Technology Analytics And Data Sciences

Cambridge, MA, US

  • Driving how the Global Safety and Regulatory Sciences engages with industry and agency telematics strategies, and bringing together technology, processes and people.
  • Engaged, representing Global Safety and Regulatory Sciences in the Business-IT governance across the R&D capabilities roadmap
  • Evolved Regulatory Systems Strategy into the Regulatory Information Management (RIM) model through development and implementation of RIM Operations, and executing the re-platform of the Regulatory operating model.
  • Assemblage of a new RIM Operations team providing the enabling operating framework to exploit the full potential in revamping the RIM ecosystem coupled with a multi-year roadmap and vision to realize and employ AI.
  • Elevated the Biogen profile across industry engagements, from evolving agency telematics related initiative to key partnerships. Member of European Medicines Agency (EMA) IDMP SPOR Task Force; Key Opinion Leader (KOL).
May 2016 - Aug 2020

Director, Worldwide Regulatory Business Technology

New York, New York, US

  • As part of the Pfizer acquisition of Hospira, aligned to the Worldwide Safety, Regulatory and Medical Business Technology organization as a Client Partner.
  • Recognized as an industry leader in R&D, Regulatory: keynote address at 1st annual Identification of Medicinal Product (IDMP) cross industry conference (CBI)
  • Primary legacy Hospira integration lead for R&D technical capabilities and data architect
  • Harmonization of the to-be 2016 PFE-HSP Regulatory BT application capabilities portfolio
Sep 2015 - May 2016

Director, It

Lake Forest, IL, US

  • Engaged to design and build a new R&D IT organization. Based on that success, was then drafted to transform the delivery of Global Enterprise Application Support with a pre-existing failing partnership, and a.
  • Orchestrated multiple changes with both new and existing strategic partners to provide key improvements to delivery while recognizing cost avoidance and savings - 40% decrease on ~$2 million annual spend in commercial.
  • Oversaw ~125 direct-indirect-outsourced global organization with $10-$15 million budget while driving process improvements throughout the operation and improving customer service
  • Designed R&D IT organization roadmap, recruited and staffed fully (no pre-existing organization or plans), while introducing new partners and delivering against ~$10 million annual delivery portfolio
  • Influenced CSO decisions to achieve IT roadmap for R&D IT portfolio, including closing out strategic selection of new Pharmacovigillance (PV) capability that had lingered for 2 years prior
  • Reset two top 10 IT Programs that had been failing through re-invigorating strategic internal and external relationships and developing new partnerships.
Sep 2012 - Sep 2015

R&D It Tower Lead

Dublin 2, IE

Accenture was chosen as the single source IT provider at a top 10 Pharmaceutical client for ongoing operations, application maintenance/development and project delivery. Responsible for the initial implementation, go-live and ongoing delivery for one of the 3 primary business-aligned towers, with an onshore/offshore application delivery team. Responsible.

Feb 2011 - Sep 2012

Associate Director, Informatics

Lawrence Township, NJ, US

  • Brought in as a recognized Oracle Life Sciences, R&D thought leader, progressed through multiple roles to deliver, architect and transform organizations, processes, operations, and new capabilities
  • Led cross-industry collaboration (“Gang of Four”: BMS, Pfizer, PPD, BI), establishing the Oracle RDC Advisory Council - Influenced Oracle Executive levels to accelerate delivery by several years of a complete.
  • Industry thought leader - Panel member for Oracle Clinical User Group (OCUG) Technical/Architecture Panel - Forester Group: Vendor and Service Management
  • Pioneered outsourced engagements. Sourcing locations spanning South America, India, Asia-Pac, and Eastern Europe and services from help desk, to full application maintenance & development and Managed Testing Services..
  • Rescued failing provider partnership, impacting 15,000+ external clients at 5,000+ globally located clinical investigator sites. - Restored operations to measurable and effective levels, while increasing span of.
  • Implemented services governance model yielding improved operational delivery with key strategic partner - 50+% improvement in service governance effectiveness - 10% effective annual cost savings across a $13+million.
Feb 2004 - Jan 2011

Senior Dba

Thousand Oaks, CA, US

Architect and technical development lead for all clinical data management systems. Included both new development and ongoing support and operationsHighlights include:- Led clinical development systems integration in the acquisition of Immunex- Consolidation from an international, multi-database/replication environment to a centralized database model for.

Nov 1999 - Feb 2004

Oracle Developer

Boston, Massachusetts, US

Moved from business roles within Clinical Data Management to full technical development role for Clinical Applications. Highlight includes leading an International team that developed SeroClin, an in-house developed (Oracle RDBMS, Forms and Reports), full clinical trials data management system, including one of the first full medical auto-encoder modules

Jul 1994 - Nov 1999
2 education records

Andy Chu education

Bachelor'S Degree, G.S., Business Information Systems

Southern New Hampshire University

Education record

Dartmouth College
FAQ

Frequently asked questions about Andy Chu

Quick answers generated from the profile data available on this page.

What company does Andy Chu work for?

Andy Chu works for Sionna Therapeutics.

What is Andy Chu's role at Sionna Therapeutics?

Andy Chu is listed as BioPharma R&D Business and Technology Executive at Sionna Therapeutics.

What is Andy Chu's email address?

AeroLeads has found 1 work email signal at @biogen.com for Andy Chu at Sionna Therapeutics.

Where is Andy Chu based?

Andy Chu is based in Cambridge, Massachusetts, United States while working with Sionna Therapeutics.

What companies has Andy Chu worked for?

Andy Chu has worked for Sionna Therapeutics, H3 Biomedicine, Biogen, Pfizer, and Hospira.

How can I contact Andy Chu?

You can use AeroLeads to view verified contact signals for Andy Chu at Sionna Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did Andy Chu attend?

Andy Chu holds Bachelor'S Degree, G.S., Business Information Systems from Southern New Hampshire University.

What skills is Andy Chu known for?

Andy Chu is listed with skills including Vendor Management, Outsourcing, Pharmaceutical Industry, Clinical Data Management, Edc, Itil, It Strategy, and It Service Management.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.